Pharsight

Drugs that contain Lacosamide

1. Motpoly Xr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11337943 AUCTA Lacosamide pharmaceutical composition and dosage form thereof
Jun, 2040

(16 years from now)

Market Authorisation Date: 04 May, 2023

Treatment: Treatment of partial-onset seizures in adults and in pediatric patients weighing at least 50 kg

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

MOTPOLY XR family patents

Family Patents

2. Vimpat patents expiration

VIMPAT Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
USRE38551 UCB INC Anticonvulsant enantiomeric amino acid derivatives
Mar, 2022

(1 year, 11 months ago)

Drug Exclusivity Drug Exclusivity Expiration
New Dosing Schedule (D) Apr 28, 2026
New Patient Population (NPP) Oct 14, 2024

Market Authorisation Date: 28 October, 2008

Treatment: Method of treating partial onset seizures in patients 4 years of age and older; Method of treating, as initial loading dose for monotherapy or adjunctive therapy, partial onset-seizures in a patient w...

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of VIMPAT before it's drug patent expiration?
More Information on Dosage

VIMPAT family patents

Family Patents